Cargando…
Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial
BACKGROUND: Recovery after a major stroke is usually limited, but cell therapy for patients with fixed neurologic deficits is emerging. Several recent clinical trials have investigated mesenchymal stem cell (MSC) therapy for patients with ischemic stroke. We previously reported the results of a cont...
Autores principales: | Kim, Suk Jae, Moon, Gyeong Joon, Chang, Won Hyuk, Kim, Yun-Hee, Bang, Oh Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016561/ https://www.ncbi.nlm.nih.gov/pubmed/24083670 http://dx.doi.org/10.1186/1745-6215-14-317 |
Ejemplares similares
-
Serum-mediated Activation of Bone Marrow–derived Mesenchymal Stem Cells in
Ischemic Stroke Patients: A Novel Preconditioning Method
por: Moon, Gyeong Joon, et al.
Publicado: (2018) -
Biomarkers for Stroke
por: Kim, Suk Jae, et al.
Publicado: (2013) -
Brain morphological and connectivity changes on MRI after stem cell therapy in a rat stroke model
por: Son, Jeong Pyo, et al.
Publicado: (2021) -
Adult Stem Cell Therapy for Stroke: Challenges and Progress
por: Bang, Oh Young, et al.
Publicado: (2016) -
The effect of remote ischemic preconditioning on serum creatinine in patients undergoing partial nephrectomy: a study protocol for a randomized controlled trial
por: Hur, Min, et al.
Publicado: (2018)